Navigation Links
Avoiding secondhand smoke during pregnancy
Date:1/27/2009

San Diego, January 27, 2009 Environmental Tobacco Smoke (ETS) commonly called secondhand smoke, can harm a developing fetus and may account for complications during pregnancy and birth. It is now known that non-whites experience more adverse pregnancy effects than do whites from smoking and ETS exposure. In an article published in the March 2009 issue of the American Journal of Preventive Medicine, researchers examined whether black, non-smoking women were able to avoid ETS exposure early in pregnancy and the social contextual factors that affected their success in avoiding secondhand smoke.

This study was conducted by investigators from The George Washington University Medical Center School of Public Health & Health Services, Children's National Medical Center, RTI International, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Data were collected from 1044 women as part of a randomized, multiplerisk behavior intervention trial that addressed four risks for adverse pregnancy outcomes: cigarette smoking, ETS exposure, depression and intimate partner violence (IPV). In this study, the investigators analyzed data from 450 non-smokers who reported having partners, friends, household or family members who smoked. Demographic factors such as age, education, marital status and household income were collected, as was reproductive history information. Attitudes about being pregnant were assessed, as were mental health-related items such as depression symptoms and alcohol or illicit drug use. Interpersonal factors included having a current partner, the father's desire to have the baby and the incidence of IPV either before or during pregnancy.

Direct ETS exposure factors such as smoking by others in the household, household smoking bans, perceived support from significant others to avoid secondhand smoke and perceived harmfulness of ETS exposure to the baby's health were also measured. To accurately determine ETS exposure, cotinine levels in the mother's saliva were measured. Cotinine is a widely accepted biomarker for tobacco exposure.

Twenty-seven percent of pregnant nonsmokers were confirmed as ETS avoiders. The odds of ETS avoidance were increased among women who reported household smoking bans, reported the father wanted the baby and where no/few family members/friends smoked. The odds were decreased among women who had a current partner, reported any intimate partner violence during pregnancy and reported little social support to prevent ETS exposure.

Writing in the article, Susan Michele Blake, PhD, The George Washington University Medical Center, School of Public Health and Health Services, states, "Results highlight the importance of comprehensive prenatal screening to identify a woman's psychosocial and behavioral risks. Before addressing ETS exposure, it is important to gain a complete understanding of the social context of a woman's pregnancy. While providing behavioral counseling and skills-based interventions, it is important to consider other factors that could exacerbate risks for IPV and poor pregnancy outcomes."


'/>"/>

Contact: AJPM Editorial Office
eAJPM@ucsd.edu
858-457-7292
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. Complimentary Pamphlet on Avoiding Snow Blower Injuries Offered by Chicago Hospital
2. Avoiding a Holiday Season of Discontent
3. Immune molecule that plays a powerful role in avoiding organ rejection identified
4. U.S. Preventive Medicine Experts Available to Discuss Role of Prevention in Avoiding Heart Attacks
5. RF Technologies Assists Healthcare Providers in Avoiding Preventable Injury Conditions to be Denied Reimbursement by Medicare
6. Dietary oil may need help in avoiding any side effects of weight loss
7. Proper Hand Hygiene Is Key to Avoiding Illness During Cold and Flu Season
8. Almost Half of Kids Still Exposed to Secondhand Smoke
9. Secondhand smoke raises odds of fertility problems in women
10. Exposure to secondhand smoke reduced
11. Ft. Lauderdale Jury Awards Couple over $3 Million in Secondhand Asbestos Exposure Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical ... partners to help with process innovation in drug formulation and manufacturing. CoreRx ... with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... ... MD is committed to providing the highest quality of spine care to all his patients. ... all my patients to alleviate possible future issues. I am pleased to have you as ... my trained staff will assist you in any way possible.” , Dr. Saad Chaudhary is ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
Breaking Medicine Technology: